GlassScriptPhysician profile
Siddhartha Varma
NPI 1598920225
$3,918.14
in general payments reported to CMS, 2019-2025
42 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,906 · 2020: $727 · 2021: $1,039 · 2022: $23.26 · 2024: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $460.63 | 2019-2021 | |
| Abbvie INC. | $424.38 | 2019-2024 | |
| Alexion Pharmaceuticals, INC. | $285.78 | 2019-2024 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $282.04 | 2019-2021 | |
| Emd Serono, INC. | $268.28 | 2019-2020 | |
| Genzyme Corporation | $255.90 | 2019-2021 | |
| Amgen INC. | $213.81 | 2019-2021 | |
| Biogen, INC. | $192.73 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $176.03 | 2020-2021 | |
| Allergan, INC. | $132.00 | 2019-2021 | |
| Lundbeck LLC | $100.18 | 2019-2021 | |
| Ucb, INC. | $96.57 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $96.43 | 2019-2021 | |
| Grifols USA, LLC | $91.13 | 2019 | |
| Livanova USA, INC. | $84.35 | 2019-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Siddhartha Varma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.